Many of these drugs feature novel mechanisms of action or routes of administration and this increased competition may eventually exert downward pressure on pricing
Progress in Biomaterials, 11 (3), 273280
Tirzepatides dual GIP/GLP-1 mechanism has demonstrated superior weight-loss efficacy in both clinical trials and real-world studies, enabling stronger payer uptake and prescriber preference
Jump to: What to expect when switching | Weight loss comparison | How to switch safely | Take home message You can switch from Wegovy (semaglutide) to Mounjaro (tirzepatide) under medical supervision, though youll need to start at a lower dose of Mounjaro and gradually increase it
The era of pushing larger portions and maximizing calorie sales is over
As obesity rates continue to decline and these medications become more widely used, with 26% of Americans planning to use GLP-1 medications to reach their 2025 New Years resolution goals, their impact on the economy could grow